MX2018008793A - Combinacion farmaceutica o nutricional que comprende beta-hidroxi-betametilbutirato. - Google Patents

Combinacion farmaceutica o nutricional que comprende beta-hidroxi-betametilbutirato.

Info

Publication number
MX2018008793A
MX2018008793A MX2018008793A MX2018008793A MX2018008793A MX 2018008793 A MX2018008793 A MX 2018008793A MX 2018008793 A MX2018008793 A MX 2018008793A MX 2018008793 A MX2018008793 A MX 2018008793A MX 2018008793 A MX2018008793 A MX 2018008793A
Authority
MX
Mexico
Prior art keywords
beta
pharmaceutical
hydroxy
betamethylbutyrate
combination
Prior art date
Application number
MX2018008793A
Other languages
English (en)
Inventor
Sathyavageeswaran Shreeram
Original Assignee
Abbott Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Lab filed Critical Abbott Lab
Publication of MX2018008793A publication Critical patent/MX2018008793A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
    • A23L2/38—Other non-alcoholic beverages
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/30—Dietetic or nutritional methods, e.g. for losing weight
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Nutrition Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Physiology (AREA)
  • Mycology (AREA)
  • Hematology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Neurology (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Child & Adolescent Psychology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)

Abstract

La presente invención se refiere a una combinación farmacéutica o nutricional que comprende beta-hidroxi beta-metilbutirato (HMB) y tetrahidrocurcumina (THC) y métodos que comprenden administrar la combinación a un sujeto. Los métodos de 5 la invención se refieren a atenuar la degradación de la proteína muscular y/o preservar la masa corporal magra en el sujeto.
MX2018008793A 2016-01-19 2017-01-16 Combinacion farmaceutica o nutricional que comprende beta-hidroxi-betametilbutirato. MX2018008793A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB1600990.4A GB201600990D0 (en) 2016-01-19 2016-01-19 Pharmaceutical or nutritional combination
PCT/US2017/013672 WO2017127333A1 (en) 2016-01-19 2017-01-16 Pharmaceutical or nutritional combination comprising beta-hydroxy-betamethylbutyrate

Publications (1)

Publication Number Publication Date
MX2018008793A true MX2018008793A (es) 2018-11-09

Family

ID=55488189

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2018008793A MX2018008793A (es) 2016-01-19 2017-01-16 Combinacion farmaceutica o nutricional que comprende beta-hidroxi-betametilbutirato.

Country Status (9)

Country Link
US (1) US20210220301A1 (es)
EP (1) EP3405186A1 (es)
JP (1) JP2019501980A (es)
CN (1) CN108495624A (es)
CA (1) CA3011633A1 (es)
GB (1) GB201600990D0 (es)
MX (1) MX2018008793A (es)
SG (1) SG11201806127XA (es)
WO (1) WO2017127333A1 (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JOP20190146A1 (ar) 2016-12-19 2019-06-18 Axcella Health Inc تركيبات حمض أميني وطرق لمعالجة أمراض الكبد
KR20200039748A (ko) 2017-08-14 2020-04-16 악셀라 헬스 인크. 간 질환 치료를 위한 아미노산 조성물
EP3810123A1 (en) 2018-06-20 2021-04-28 Axcella Health Inc. Compositions and methods for the treatment of fat infiltration in muscle
EP3855945A1 (en) * 2018-09-25 2021-08-04 Roquette Freres Food composition containing a mixture of leguminous proteins and casein
JP2020195286A (ja) * 2019-05-31 2020-12-10 株式会社東洋新薬 経口組成物
US11872197B2 (en) * 2020-03-03 2024-01-16 Another Chance Nutra, LLC Method of treatment or alleviating symptoms of a disorder with curcumin

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20110064720A1 (en) * 2009-09-16 2011-03-17 Daniel Moses Amato Dietary Supplement Compositions and Methods of Making and Using the Same
MX2013007572A (es) 2010-12-27 2013-07-22 Abbott Lab Metodos para facilitar la recuperacion muscular despues de un periodo de desuso utilizando beta-hidroxi-beta-metilbutirato.
WO2012097061A1 (en) 2011-01-13 2012-07-19 Abbott Laboratories Nutritional compositions and methods for improving skeletal muscle protein metabolism
EP2580967A1 (en) * 2011-10-11 2013-04-17 Nestec S.A. Accelerating muscle recovery after immobilization-induced muscle atrophy
WO2014028607A1 (en) * 2012-08-14 2014-02-20 Abbott Laboratories Low glycemic index nutritional compositions for preserving muscle mass and improving body composition in diabetics

Also Published As

Publication number Publication date
EP3405186A1 (en) 2018-11-28
JP2019501980A (ja) 2019-01-24
CN108495624A (zh) 2018-09-04
SG11201806127XA (en) 2018-08-30
US20210220301A1 (en) 2021-07-22
WO2017127333A1 (en) 2017-07-27
GB201600990D0 (en) 2016-03-02
CA3011633A1 (en) 2017-07-27

Similar Documents

Publication Publication Date Title
MX2018008793A (es) Combinacion farmaceutica o nutricional que comprende beta-hidroxi-betametilbutirato.
MX2022004374A (es) Composiciones de agonista de tlr9 e inhibidores de punto de control para usarse en la respuesta inmune contra el cancer.
PH12019501339A1 (en) Amino acid compositions and methods for the treatment of muscle diseases and disorders
PH12019501010A1 (en) Arginase inhibitor combination therapies
BR112016024352A2 (pt) ?cepa de listeria recombinante, listeria recombinante, composição farmacêutica, e, métodos de induzir uma resposta imune contra um tumor ou um câncer em um indivíduo humano e de listeria?
PH12018502714A1 (en) Nicotine particles and compositions
MX2017015702A (es) Composiciones farmaceuticas y alimenticias para inducir la saciedad y prolongar la saciedad en sujetos que lo necesitan.
MY174991A (en) Eurycoma longifolia extract and its use in enhancing and/or stimulating immune system
PH12015501870B1 (en) Nutritional compositions containing a peptide component with adiponectin stimulating properties and uses thereof
MX2016008495A (es) Composicion nutricional pediatrica con peptidos lacteos para un crecimiento y desarrollo saludable.
EA201691436A1 (ru) Композиция, включающая окру для применения в уменьшении абсорбции пищевого жира
MX2018002546A (es) Composiciones que comprenden un compuesto de urolitina.
WO2015123493A3 (en) Compositions and methods for modulatuion of immune response
MX2017006639A (es) Metodos y composiciones para preservar la masa corporal magra y promover la perdida de grasa durante la perdida de peso.
JO3565B1 (ar) الأجسام المضادة لشبيه الأنجيوبوييتين– 4 وطرق استخدامها
TW201613977A (en) Angiopoetin-like 4 (ANGPTL4) antibodies and methods of use
PH12018500772A1 (en) Bird feed and in particular poultry feed, comprising synthetic capsaicinoid derivatives and such feed for prohylactic use or treatment of salmonella infection
NZ730708A (en) Vaccine compositions comprising tryptophan 2,3-dioxygenase or fragments thereof
MX2019006446A (es) Métodos para inducir tolerancia inmunológica a factores de coagulación.
MX2018007408A (es) Uso de adyuvantes para la prevencion y/o el tratamiento de enfermedades autoinmunes.
MX2017006638A (es) Metodos y composiciones para el incremento de la masa corporal magra y minimizar la ganancia de grasa corporal y el control del peso.
WO2016072692A3 (ko) 네크록스를 유효성분으로 함유하는 점막염 예방 또는 치료용 조성물
MX2019014090A (es) Métodos para el tratamiento de la reservoritis crónica.
PH12017501979A1 (en) Pharmaceutical compound
PH12016502284B1 (en) Cough medicine containing ambroxol hydrochloride